iRhythm Technologies

company

About

iRhythm Technologies provides diagnostic monitoring solutions that facilitate the early diagnosis and treatment of cardiac arrhythmia.

Details

Last Funding Type
Series D
Last Funding Money Raised
$16M
Industries
Health Care,Health Diagnostics,Medical Device,mHealth,Wearables
Founded date
Jan 1, 2006
Number Of Employee
101 - 250
Operating Status
Active
Stock Symbol
nasdaq:IRTC
Legal Name
iRhythm Technologies, Inc.

iRhythm provides innovative and cost-effective diagnostic monitoring solutions that facilitate early diagnosis and treatment decisions, with the goal of ultimately improving patient health outcomes and reducing wasteful healthcare spending. Its flagship product, the Zio® Patch, is designed to optimize and simplify the diagnosis of cardiac arrhythmias. Zio® Patch is the smallest, lightest, least conspicuous cardiac arrhythmia diagnostic available and is indicated for up to 14-day monitoring.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
14
$575.17M
iRhythm Technologies has raised a total of $575.17M in funding over 2 rounds. Their latest funding was raised on Aug 21, 2020 from a Post-IPO Secondary round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 21, 2020 Post-IPO Secondary $220M Detail
Sep 11, 2019 Post-IPO Equity $115M Detail
Oct 20, 2016 IPO $107M Detail
May 22, 2014 Series E $27.34M 2 Novo Holdings Detail
Apr 10, 2013 Series D $16M 5 Norwest Venture Partners Detail

Investments

Number of Investments
Number of Lead Investments
2
0
iRhythm Technologies has made 2 investments. Their most recent investment was on Oct 10, 2019, when Parsley Health raised $26M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 10, 2019 Parsley Health
Series B $26M Health Care
Apr 21, 2016 Sibly
Seed Health Care

Employee Profiles

Number of Employee Profiles
18
iRhythm Technologies has 18 current employee profiles, including Employee David Stoffel
Employee
Executive
Executive
Executive
Employee